SCHEMBL15570489

SCHEMBL15570489

CC(CN)O[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14369217 1.00
Nitric Acid SCHEMBL4417968 0.93 CA5A (0.35)
Nitric Acid SCHEMBL9205565 0.93 CA5A (0.35)
SCHEMBL15570344 0.81
SCHEMBL15570490 0.79 ALDH1A1 (0.33)
SCHEMBL14476657 0.79 PTGS1 (0.33)
SCHEMBL11669919 0.79 PTGS1 (0.33)
SCHEMBL11472576 0.77 ALDH1A1 (0.32)
SCHEMBL12753941 0.77 CPA1 (0.39)
SCHEMBL12374867 0.77 CPA1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2887927-B1 EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE CARDIOLYNX AG (CH) 2018-03-28 EP claimed
US-20180036259-A1 NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION MIRANDAPHARMACEUTICALS AG (CH) 2018-02-08 US claimed
US-20180008558-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2018-01-11 US claimed
US-20170100350-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2017-04-13 US claimed
WO-2016135262-A1 NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION CARDIOLYNX AG (CH) 2016-09-01 WO claimed
WO-2016135263-A1 NO DONORS FOR THE TREATMENT OF STRESS-INDUCED PULMONARY HAEMORRHAGE IN ANIMALS SCHERHAG ARMIN (CH) 2016-09-01 WO claimed
CN-104869985-A Extended release compositions of an aminoalkyl nitrate CARDIOLYNX AG 2015-08-26 CN claimed
US-20150216992-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2015-08-06 US claimed
EP-2887927-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE Cardiolynx AG (CH) 2015-07-01 EP claimed
WO-2014029841-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2014-02-27 WO claimed
EP-2887927-B1 EXTENDED RELEASE COMPOSITIONS OF AN AMINO-C2-C6-ALKYL NITRATE CARDIOLYNX AG (CH) 2018-03-28 EP disclosed
US-20180036259-A1 NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION MIRANDAPHARMACEUTICALS AG (CH) 2018-02-08 US disclosed
US-20180008558-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2018-01-11 US disclosed
US-20170100350-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2017-04-13 US disclosed
WO-2016135262-A1 NO DONORS FOR THE TREATMENT OF IMPAIRED TISSUE PERFUSION CARDIOLYNX AG (CH) 2016-09-01 WO disclosed
WO-2016135263-A1 NO DONORS FOR THE TREATMENT OF STRESS-INDUCED PULMONARY HAEMORRHAGE IN ANIMALS SCHERHAG ARMIN (CH) 2016-09-01 WO disclosed
CN-104869985-A Extended release compositions of an aminoalkyl nitrate CARDIOLYNX AG 2015-08-26 CN disclosed
US-20150216992-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2015-08-06 US disclosed
EP-2887927-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE Cardiolynx AG (CH) 2015-07-01 EP disclosed
WO-2014029841-A1 EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE CARDIOLYNX AG (CH) 2014-02-27 WO disclosed